Targets of bioactive compounds isolated from nature are identified and their binding properties are determined using molecular modelling software. Derivatives with better binding properties are designed, synthesized and evaluated biologically. Structure activity relationships of these derivatives are investigated. Compounds with good safety profiles and biological activities  are developed further as potential anti-infective, anti-inflammatory and cardiovascular agents.